ABCL News and Press, AbCellera Biologics Inc. From 05/05/23

2023-05-05 00:30:31 ET Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL) Q1 2023 Earnings Call May 04, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: AbCellera Biologics (ABCL) Q1 2023 Earnings Call...

2023-05-04 21:30:23 ET AbCellera Biologics Inc. (ABCL) Q1 2023 Results Conference Call May 04, 2023 05:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Dr. Carl Hansen - Chairman, Chief Executive Officer, and President Andrew Booth ...

2023-05-04 16:43:39 ET AbCellera Biologics press release ( NASDAQ: ABCL ): Q1 GAAP EPS of -$0.14. Revenue of $12M. Shares -3.8% . Total cumulative partnered program starts of 101, up 20% from Q1 2022 Net loss of $0.14 per share on a basic and diluted basis,...

Total revenue of $12 million, compared to $317 million in Q1 2022 Total cumulative partnered program starts of 101, up 20% from Q1 2022 Net loss of $0.14 per share on a basic and diluted basis, compared to net earnings of $0.59 (basic) and $0.54 (diluted) per share in ...

2023-04-27 09:24:55 ET With its Q1 2023 results Thursday, Eli Lilly ( NYSE: LLY ) missed Street forecasts for revenue as sales of COVID-19 antibody plummeted leading to sharp contractions in top and bottom-line. Compared to ~$1.5B in Q1 2023 and $187.5M in the consensus, the com...

2023-04-26 11:32:44 ET Eli Lilly ( NYSE: LLY ) is expected to report its Q1 2023 results before the opening bell on Thursday for a market on the lookout for updates on its pipeline led by Alzheimer’s candidate donanemab and weight loss agent tirzepatide. Amid waning deman...

In-depth characterization of CD3-binding antibodies reveals molecules with binding and functional properties that are differentiated from antibodies commonly used for T-cell engager development Discovery of antibodies with high specificity for a peptide-MHC complex demonstrates capabiliti...

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 2023 Bloom Burton & Co. Healthcare Investor Conference in Toronto on Tuesday, April 25, 2023, at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time). A live audio webcast of the presentation may be...

2023-04-10 22:25:44 ET The U.S. government is launching a $5B-plus program to accelerate the development of new coronavirus vaccines and treatments, officials from the Biden administration and the Department of Health and Human Services ( HHS ) confirmed Monday. An HHS official said...

AbCellera (Nasdaq: ABCL) will announce its first quarter 2023 financial results on Thursday, May 4, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that...